Shah, N.A., Paul, S., Parveen, S., Bhat, M.H., Ali, I. and Kadla, S.A. 2025. Therapeutic outcome of saroglitazar, a peroxisome proliferator activated receptor α/γ agonist in diabetic and non-diabetic metabolic dysfunction associated steatotic liver disease. International Journal of Basic & Clinical Pharmacology. 14, 4 (Jun. 2025), 519–525. DOI:https://doi.org/10.18203/2319-2003.ijbcp20251836.